Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000700489 | SCV000829246 | pathogenic | Developmental and epileptic encephalopathy, 33 | 2023-01-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on EEF1A2 protein function. ClinVar contains an entry for this variant (Variation ID: 577676). This missense change has been observed in individual(s) with clinical features of EEF1A2-related conditions (Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 381 of the EEF1A2 protein (p.Arg381Trp). |
Institute of Human Genetics, |
RCV001255362 | SCV001431692 | likely pathogenic | Intellectual disability | 2020-08-03 | criteria provided, single submitter | clinical testing | The variant c.1141C>T, p.(Arg381Trp) was identified in an individual with neurodevelopmental disorder (NDD) and classified as Likely pathogenic according to ACMG guidelines. Inheritance for this variant was not maternal.The variant likely explains the NDD in this individual. |
Institute of Human Genetics, |
RCV000700489 | SCV001439922 | uncertain significance | Developmental and epileptic encephalopathy, 33 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Department of Genetics, |
RCV003444649 | SCV004171548 | likely pathogenic | not provided | 2018-04-26 | no assertion criteria provided | clinical testing |